These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2735737)

  • 21. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems in cardiology. Correlations between the types of hyperlipoproteinemias. Clinically manifested atherosclerosis and risk factors. Comparative functional study of 5 criteria of classification].
    Mihail A; Popescu P; Idu SM; Petrescu X; Cociumian L; Mihai N
    Med Interna (Bucur); 1972 Oct; 24(10):1195-206. PubMed ID: 4650750
    [No Abstract]   [Full Text] [Related]  

  • 23. [Specific features of cardiovascular diseases in patients with mono- and polygenic types of dyslipoproteinemia].
    Ol'binskaia LI; Zakharova VL
    Vestn Ross Akad Med Nauk; 1998; (10):56-60. PubMed ID: 9846115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laboratory diagnosis of lipid imbalance].
    Siemianowicz K
    Wiad Lek; 1996; 49(7-12):159-65. PubMed ID: 9245112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of path analysis in coronary heart disease research.
    Rao DC; Province MA; Wette R; Glueck CJ
    Prog Clin Biol Res; 1984; 147():193-212. PubMed ID: 6610877
    [No Abstract]   [Full Text] [Related]  

  • 26. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 27. Plafibride treatment and serum lipids in hyperlipoproteinemias.
    Rodriguez F; López IM; Jover E
    J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of the lipidogram (Lees-Hatch technic) associated with the determination of serum lipid fractions for the detection and classification of hyperlipoproteinemias. (Apropos of 100 arteriosclerosis patients)].
    Loeper J; Tricot R; Rouffy J
    Presse Med (1893); 1969 Jan; 77(5):171-2. PubMed ID: 5771795
    [No Abstract]   [Full Text] [Related]  

  • 30. [Frameworks of recognition and classification of primary hyperlipidemia].
    de Gennes JL
    Bull Acad Natl Med; 1994 Mar; 178(3):381-8; discussion 388-91. PubMed ID: 8076178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mixed dyslipoproteinemias: new therapeutic opportunities].
    Capurso A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():44S-47S. PubMed ID: 8562265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dyslipidemias and coronary disease].
    Douste-Blazy P; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(5):559-64. PubMed ID: 3544979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
    Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Status quo of lipid diagnosis from the internal medicine viewpoint].
    Reuter W
    Z Gesamte Inn Med; 1988 Feb; 43(3):71-4. PubMed ID: 3369219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study.
    Wallace RB; Pomrehn P; Heiss G; Chambless LE; Johnson N; Patten R; Lippel K; Rifkind BM
    Circulation; 1986 Jan; 73(1 Pt 2):I62-9. PubMed ID: 3940685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-degree kinship with young coronary artery disease patients markedly increases lipid-level disorders in asymptomatic hypertensives.
    Giannini SD; Diament J; Forti N; Issa JS; Dal Bó C; Fukushima J; Barretto AC
    J Cardiovasc Risk; 1998 Jun; 5(3):141-5. PubMed ID: 10201549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segregation analysis: a gene or not a gene. .
    Lalouel JM
    Prog Clin Biol Res; 1984; 147():217-43. PubMed ID: 6377313
    [No Abstract]   [Full Text] [Related]  

  • 40. [Classification of the hyperlipoproteinemias].
    Huth K
    Med Klin; 1970 Apr; 65(14):637-43. PubMed ID: 4927439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.